Akebia Therapeutics AKBA Earnings Call Transcripts

NASDAQ AKBA
$0.57 +0.03 (+5.89%)
At close: Nov 11, 2026 · 4:00 PM EST
8 earnings calls on file for Akebia Therapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Akebia Therapeutics Q3 2026 Earnings Call

Nov 5, 2026 6,484 words · 28 min read
  • John ButlerChief Executive Officer
  • Erik OstrowskiChief Financial and Chief Business Officer
  • Dr. Steven BurkeChief Medical Officer
  • Nicholas GrundChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Akebia Therapeutics Earnings Call Transcripts

Calls8
LatestNov 5, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 8 Akebia Therapeutics transcripts Register to get access to Akebia Therapeutics’s earnings call transcripts.